Sit Investment Associates’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.7M Sell
83,185
-95
-0.1% -$3.42K 0.07% 234
2026
Q1
$2.68M Buy
83,280
+3,100
+4% +$110K 0.05% 264
2025
Q4
$2.89M Sell
80,180
-3,000
-4% -$110K 0.06% 269
2025
Q3
$2.62M Hold
83,180
0.05% 278
2025
Q2
$3.54M Buy
83,180
+21,530
+35% +$896K 0.08% 237
2025
Q1
$2.75M Sell
61,650
-2,880
-4% -$155K 0.06% 272
2024
Q4
$3.54M Buy
64,530
+35
+0.1% +$1.77K 0.08% 255
2024
Q3
$2.73M Buy
64,495
+4,750
+8% +$226K 0.06% 274
2024
Q2
$2.74M Buy
59,745
+18,167
+44% +$857K 0.06% 259
2024
Q1
$2.16M Buy
41,578
+13,028
+46% +$571K 0.05% 289
2023
Q4
$1.02M Buy
28,550
+5,125
+22% +$178K 0.02% 356
2023
Q3
$785K Buy
+23,425
New +$812K 0.02% 361

Other funds holding VCEL

Sit Investment Associates's VCEL Position: Q2 2026 in Review

Sit Investment Associates reduced its Vericel Corp (VCEL) stake by 0.11% in Q2 2026, selling an estimated $3.42K and leaving 83,185 shares worth $3.7M. The position accounts for 0.07% of the portfolio, ranked #234.

Sit Investment Associates first reported a position in VCEL in Q3 2023 and has held it in 12 quarters since. 319 funds tracked by Wall St. Rank hold VCEL as of Q2 2026.

  • Sit Investment Associates held 83,185 shares of Vericel Corp worth $3.7M as of Q2 2026.
  • Sit Investment Associates sold 95 Vericel Corp shares in Q2 2026, an estimated $3.42K.
  • Vericel Corp made up 0.07% of Sit Investment Associates's portfolio in Q2 2026, its #234 holding.
  • Sit Investment Associates first reported a position in Vericel Corp in Q3 2023 and has held it in 12 quarters since.
  • 319 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2026.

Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.